The effect of novel fluorapatite surfaces on osteoblast-like cell adhesion, growth, and mineralization.
There is increasing demand for biomedical implants to correct skeletal defects caused by trauma, disease, or genetic disorder. In this study, the MG-63 cells were grown on metals coated with ordered and disordered fluorapatite (FA) crystal surfaces to study the biocompatibility, initial cellular response, and the underlying mechanisms during this process. The long-term growth and mineralization of the cells were also investigated. After 3 days, the cell numbers on etched metal surface are significantly higher than those on the ordered and disordered FA surfaces, but the initial adherence of a greater number of cells did not lead to earlier mineral formation at the cell-implant interface. Of the 84 cell adhesion and matrix-focused pathway genes, an up- or down-regulation of a total of 15 genes such as integrin molecules, integrin alpha M and integrin alpha 7 and 8 was noted, suggesting a modulating effect on these adhesion molecules by the ordered FA surface compared with the disordered. Osteocalcin expression and the mineral nodule formation are most evident on the FA surfaces after osteogenic induction (OI) for 7 weeks. The binding of the ordered FA surfaces to the metal, with and without OI, was significantly higher than that of the disordered FA surfaces with OI. Most significantly, even without the OI supplement, the MG-63 cells grown on FA crystal surfaces start to differentiate and mineralize, suggesting that the FA crystal could be a simple and bioactive implant coating material.
Liu
Jun
J
Department of Cariology, Restorative Sciences and Endodontics, Dental School, University of Michigan, Ann Arbor, Michigan 48109, USA.
Jin
Taocong
T
Chang
Syweren
S
Czajka-Jakubowska
Agata
A
Zhang
Zhaocheng
Z
Nör
Jacques E
JE
Clarkson
Brian H
BH
D001031:Apatites / Q000494:pharmacology*; D015153:Blotting, Western; D002448:Cell Adhesion / Q000187:drug effects*; D002454:Cell Differentiation / Q000187:drug effects*; D045744:Cell Line, Tumor; D049109:Cell Proliferation / Q000187:drug effects*; D005434:Flow Cytometry; D006801:Humans; D008855:Microscopy, Electron, Scanning; D010006:Osteoblasts / Q000166:cytology* / Q000187:drug effects* / Q000378:metabolism / Q000648:ultrastructure; D020133:Reverse Transcriptase Polymerase Chain Reaction
D001031:Apatites; C025105:fluorapatite
J Biomed Mater Res B Appl Biomater. 2004 Apr 15;69(1):33-7
15015207
J Biomed Mater Res A. 2009 May;89(2):326-35
18431794
Tissue Eng. 2006 Apr;12(4):927-37
16674304
Biomaterials. 2000 Sep;21(17):1803-10
10905463
Biomaterials. 2005 Aug;26(24):4938-43
15769528
Biomaterials. 1998 Aug;19(16):1419-23
9794512
Artif Organs. 2006 Jan;30(1):5-6
16409390
Adv Dent Res. 1999 Jun;13:27-33
11276743
Biomaterials. 2005 Nov;26(32):6288-95
15913766
J Biomed Mater Res B Appl Biomater. 2006 Oct;79(1):108-15
16470834
J Biomed Mater Res A. 2007 Mar 1;80(3):687-92
17109412
Biomaterials. 2002 Sep;23(17):3651-9
12109691
Int Endod J. 2003 Aug;36(8):564-70
12887386
Arch Oral Biol. 1992 Dec;37(12):1045-55
1335227
Nutrition. 2007 Oct;23(10):745-53
17664058
J Biol Chem. 1994 Oct 7;269(40):24756-61
7929152
Biomaterials. 1995 Sep;16(14):1057-67
8519926
J Mater Sci Mater Med. 2000 Dec;11(12):787-92
15348061
J Mater Sci Mater Med. 2005 May;16(5):399-404
15875248
Nature. 2003 Oct 30;425(6961):977-80
14586470
J Biomed Mater Res. 1993 Nov;27(11):1401-7
8263002
Biomaterials. 2007 Nov;28(31):4535-50
17644175
Biomaterials. 2004 Mar-Apr;25(7-8):1375-84
14643612
Cryst Growth Des. 2006 Jun 1;6(6):1504-1508
19513184
J Am Chem Soc. 2005 Jun 8;127(22):8168-73
15926845
Biomaterials. 2004 Aug;25(17):3351-8
15020107
J Mater Sci Mater Med. 2007 May;18(5):705-14
17143739
Biomaterials. 2006 Jun;27(16):3096-108
16460797
Adv Dent Res. 1999 Jun;13:38-48
11276745